Neocarzinostatin - The Past, Present, and Future of Anticancer Drug (Paperback, Softcover reprint of the original 1st ed. 1997)

The 20th century has witnessed the great benefits of the development of antibi otics, which became a reality after World War IL More than 50 years ago I witnessed the miraculous therapeutic power of penicillin, when I was a student at the Tohoku University Medical School's Department of Bacteriology in Sendai, Japan. The late Dr. Kondo was a graduate student in the department at that time and developed the first crude penicillin preparation in Japan which was applied with dramatic results in two patients. Although there was patient-family consent at that time, ethics committees, randomization. mutagenesis tests, distribution studies, purity-criteria, and phar macokinetics were not yet in existence. Today, regulatory procedures have com plicated the whole drug-approval process. For example, any new antibiotics that have been proven effective in laboratory studies against gram-negative bacteria, as might exist in deadly plague bacteria, must still undergo a long and enormously costly regulatory process before they can be introduced to benefit society, and before government insurance can be applied.

General

Imprint:	Springer Verlag,Japan
Country of origin:	Japan
Release date:	October 2013
First published:	1997
Editors:	Hiroshi Maeda • Kiyoto Edo • Nakao Ishida
Dimensions:	229 x 152 x 16mm (L x W x T)
Format:	Paperback
Pages:	287
Edition:	Softcover reprint of the original 1st ed. 1997
ISBN-13:	978-4-431-66916-6
Categories:	Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > General Promotions
LSN:	4-431-66916-7
Barcode:	9784431669166

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!